CV Sciences, Inc. Announces Silver Level Sponsorship of the 15th Annual Nutrition and Health Conference in Boston, Massachusetts - April 29-May 2, 2018
18 avr. 2018 08h45 HE
|
CV Sciences, Inc.
Company Continues its Expansion into the Healthcare Professional Market through One-on-One Education, Exclusive Product Offerings and Enhanced Practitioner Support. LAS VEGAS, April 18, 2018 (GLOBE...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
04 avr. 2018 08h45 HE
|
CV Sciences, Inc.
Company Further Reduces Debt and Avoids Dilution to Stockholders LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
29 mars 2018 15h26 HE
|
CV Sciences, Inc.
- Record Year on All Key Financial Performance Metrics - Management to Host Webcast on March 29, 2018 to Discuss Q4 2017 and Full Year 2017 Operating Results LAS VEGAS, March 29, 2018 (GLOBE...
CV Sciences, Inc. to Host Fourth Quarter and Year End 2017 Financial Results Conference Call on Thursday, March 29, 2018
22 mars 2018 19h00 HE
|
CV Sciences, Inc.
LAS VEGAS, March 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
06 mars 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, March 06, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the February and March 2018 installment...
CV Sciences, Inc. to Present at the 30th Annual ROTH Conference in Dana Point, California, March 11-14, 2018
28 févr. 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that it...
CV Sciences, Inc. to Present and Exhibit as Silver Sponsor at Natural Products Expo West 2018 in Anaheim, California, March 7-11, 2018
13 févr. 2018 05h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Feb. 13, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that its...
CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018
24 janv. 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Jan. 24, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting its industry-dominating brand of...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
16 janv. 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Jan. 16, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the January 2018 installment obligation...
CV Sciences, Inc. to Present at the Biotech Showcase™ 2018
03 janv. 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids,...